semaglutide and alzheimer's Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US - Wang - 2024

23.63

★★★★☆4.8 (126)

Semaglutide May Lower Alzheimer's Risk for Diabetics

22.86

★★★★★4.9 (98)

Observational data indicated that semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in individuals with type 2 diabetes. Read more at the link in our bio. #ozempic #Semaglutide #

20.20

★★★★★5.0 (157)

Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment

22.46

★★★★★4.7 (84)

Oral Ozempic for earlier Alzheimer's? NOPE. "Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials ..." "Interpretation:

20.42

★★★★★4.9 (203)

Semaglutide Reduces Alzheimer's Risk in Diabetics – IAS EXPRESS

20.96

★★★★★5.0 (176)

Semaglutide and Alzheimer's: are we seeing signals in the brain biology? Semaglutide is a GLP-1 analog, which means it mimics a hormone involved in metabolism and may also influence inflammation and brain

25.06

★★★★★4.8 (132)